112 related articles for article (PubMed ID: 15975539)
21. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
[TBL] [Abstract][Full Text] [Related]
22. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
23. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
Torriani FJ; Rodriguez-Torres M; Rockstroh JK; Lissen E; Gonzalez-García J; Lazzarin A; Carosi G; Sasadeusz J; Katlama C; Montaner J; Sette H; Passe S; De Pamphilis J; Duff F; Schrenk UM; Dieterich DT;
N Engl J Med; 2004 Jul; 351(5):438-50. PubMed ID: 15282351
[TBL] [Abstract][Full Text] [Related]
24. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.
Maddrey WC
Semin Liver Dis; 1999; 19 Suppl 1():67-75. PubMed ID: 10349694
[TBL] [Abstract][Full Text] [Related]
25. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
[TBL] [Abstract][Full Text] [Related]
26. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
27. A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
Saracco G; Ciancio A; Olivero A; Smedile A; Roffi L; Croce G; Colletta C; Cariti G; Andreoni M; Biglino A; Calleri G; Maggi G; Tappero GF; Orsi PG; Terreni N; Macor A; Di Napoli A; Rinaldi E; Ciccone G; Rizzetto M
Hepatology; 2001 Jul; 34(1):133-8. PubMed ID: 11431744
[TBL] [Abstract][Full Text] [Related]
28. Effects of ribavirin combined with interferon-alpha 2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads.
Enomoto M; Nishiguchi S; Kohmoto M; Tamori A; Habu D; Takeda T; Seki S; Shiomi S
J Viral Hepat; 2004 Sep; 11(5):448-54. PubMed ID: 15357651
[TBL] [Abstract][Full Text] [Related]
29. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.
Liu CJ; Chen PJ; Lai MY; Kao JH; Jeng YM; Chen DS
Hepatology; 2003 Mar; 37(3):568-76. PubMed ID: 12601355
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
Shimoyama T; Sawada K; Hiwatashi N; Sawada T; Matsueda K; Munakata A; Asakura H; Tanaka T; Kasukawa R; Kimura K; Suzuki Y; Nagamachi Y; Muto T; Nagawa H; Iizuka B; Baba S; Nasu M; Kataoka T; Kashiwagi N; Saniabadi AR
J Clin Apher; 2001; 16(1):1-9. PubMed ID: 11309823
[TBL] [Abstract][Full Text] [Related]
31. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
[TBL] [Abstract][Full Text] [Related]
32. Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study.
Morabito V; Novelli S; Poli L; Ferretti G; Ruberto F; Pugliese F; Pretagostini R; Berloco PB; Rossi M
Transplant Proc; 2016 Mar; 48(2):352-8. PubMed ID: 27109954
[TBL] [Abstract][Full Text] [Related]
33. Adacolumn treatment in kidney transplant patients with hepatitis C virus.
Novelli G; Rossi M; Ferretti G; Poli L; Pretagostini R; Ruberto F; Morabito V; Cinti P; Nudo F; Mennini G; Berloco PB
Transplant Proc; 2009 May; 41(4):1195-200. PubMed ID: 19460515
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.
Ruuska T; Küster P; Grahnquist L; Lindgren F; Wewer AV
World J Gastroenterol; 2016 May; 22(17):4389-96. PubMed ID: 27158208
[TBL] [Abstract][Full Text] [Related]
36. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
Rodríguez-Lago I; Benítez JM; García-Sánchez V; Gutiérrez A; Sempere L; Ginard D; Barreiro-de Acosta M; Cabriada JL
Gastroenterol Hepatol; 2018; 41(7):423-431. PubMed ID: 29739692
[TBL] [Abstract][Full Text] [Related]
38. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
World J Gastroenterol; 2006 Jan; 12(4):520-5. PubMed ID: 16489663
[TBL] [Abstract][Full Text] [Related]
39. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
[TBL] [Abstract][Full Text] [Related]
40. Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis.
Watanabe K; Uchida Y; Sugawara K; Naiki K; Inao M; Nakayama N; Mochida S
J Gastroenterol; 2017 Jul; 52(7):830-837. PubMed ID: 27858246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
